Mantle cell lymphoma (MCL) is an uncommon type of non-Hodgkin lymphoma that is frequently aggressive. The majority of patients are older and present with advanced-stage disease. While the treatment landscape is rapidly evolving with an increasing number of options, there is still no curative treatment.
Although many patients initially respond to first-line therapy, the duration of remission is generally short. More effective therapies are still needed in patients with relapsed or refractory disease.
How much do you know about relapsed/refractory MCL? Test your knowledge with this quick quiz.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ann S. LaCasce. Fast Five Quiz: Relapsed/Refractory Mantle Cell Lymphoma - Medscape - Jan 12, 2023.
Comments